Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON
  1. Home
  2. Azioni
  3. Stati Uniti
  4. Nasdaq
  5. Veru Inc.
  6. Notizie
  7. Altre lingue
    VERU   US92536C1036

VERU INC.

(VERU)
RiassuntoQuotazioniGraficiNotizieRatingAgendaSocietąFinanzaConsensusRevisioniDerivati 
RiassuntoTutte le notizieRaccomandazione analistiAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Notizie in altre lingue su VERU INC.
02/12VERU INC. Management's Discussion and Analysis of Financial Condition and Results of O..
02/12Veru Inc. Reports Earnings Results for the Full Year Ended September 30, 2021
02/12VERU: Reports Record Fiscal 2021 Full-Year Financial Results —FY21 Net Revenues Incr..
02/12Veru Inc. Reports Earnings Results for the Fourth Quarter Ended September 30, 2021
02/12Veru's Fiscal Q4 Loss Narrows, Revenue Rises
02/12Veru Reports Record Fiscal 2021 Full-Year Financial Results
02/12NORTH AMERICAN MORNING BRIEFING: Stock Futures -3-
18/11Veru to Report Fiscal 2021 Fourth-Quarter, Full-Year Financial Results, Host Conference..
18/11Veru Ranked as one of the Fastest-Growing Companies in North America on the 2021 Deloit..
08/11Veru to Participate in Fireside Chat at the Jefferies London Healthcare Conference on N..
13/10VERU: Enrolls First Patient in Phase 3 Study of Breast Cancer Drug Candidate
13/10VERU: Enrolls First Patient in International Phase 3 ARTEST Clinical Trial of Enobosarm i..
13/10Veru Enrolls First Patient in International Phase 3 ARTEST Clinical Trial of Enobosarm ..
20/09VERU: Says Phase 1b/2 Trial of Sabizabulin in Prostate Cancer Shows Overall Response Rate..
20/09VERU: Announces Positive Updated Data from Phase 1b/2 Sabizabulin Study in Men with Metas..
20/09Veru Announces Positive Updated Data from Phase 1B/2 Sabizabulin Study in Men with Meta..
09/09VERU: Announces Oral Presentation of Updated Data from the Phase 1b/2 Sabizabulin Study i..
08/09VERU: to Present at Three Upcoming Healthcare Investment Conferences
12/08VERU: Management's Discussion and Analysis of Financial Condition and Results of Operatio..
12/08VERU: Sets Another Quarterly Record in Both Net Revenues and in Gross Profit for Fiscal 2..
12/08VERU: Fiscal Q3 Loss Narrows, Revenue Grows; Shares Climb Pre-Bell
12/08VERU: Earnings Flash (VERU) VERU Posts Q3 Revenue $17.7M, vs. Street Est of $14.1M
12/08VERU: Earnings Flash (VERU) VERU Posts Q3 Loss $-0.03, vs. Street Est of $-0.06
12/08VERU: Sets Another Quarterly Record in Both Net Revenues and in Gross Profit for Fiscal 2..
12/08Veru Inc. Reports Earnings Results for the Third Quarter Ended June 30, 2021
29/07VERU: to Report Fiscal 2021 Third-Quarter Financial Results, Host Conference Call on Augu..
28/06Veru Announces the Presentation of a Phase 1b/2 Clinical Study Update for Sabizabulin (..
28/06Veru Inc. Announces Updated Clinical Results from the Ongoing Phase 1B/2 Clinical Study..
25/06VERU: Begins Enrollment in Phase 3 Trial of Sabizabulin in Prostate Cancer
25/06Veru Enrolls First Patient in Phase 3 VERACITY Clinical Trial of Sabizabulin (VERU-111)..
25/06Veru Inc. Announces Enrolls First Patient in Phase 3 Veracity Clinical Trial of Sabizab..
25/06VERU INC.(NASDAQCM: VERU) added to Russell 2000 Value Index
25/06VERU INC.(NASDAQCM: VERU) added to Russell 3000E Value Index
25/06VERU INC.(NASDAQCM: VERU) added to Russell Small Cap Comp Value Index
25/06VERU INC.(NASDAQCM: VERU) added to Russell 3000 Value Index
25/06VERU INC.(NASDAQCM: VERU) added to Russell Microcap Value Index
25/06VERU INC.(NASDAQCM: VERU) added to Russell 2500 Value Index
10/06Veru Enrolls First Patient in Phase 2 Clinical Trial of VERU-100, Novel Long-acting GnR..
10/06Veru Inc. Enrolls First Patient in Phase 2 Clinical Trial of VERU-100, Novel Long-actin..
07/06VERU ANNOUNCES POSITIVE PHASE 2 CLIN: Efficacy of Enobosarm Therapy Correlates with Andro..
07/06Veru Inc. Announces Positive Phase 2 Clinical Data
07/06Veru Announces Positive Phase 1b/2 Clinical Study Update for Sabizabulin (VERU-111) in ..
07/06Veru Announces Positive Phase 1b/2 Clinical Study Update for Sabizabulin (VERU-111) in ..
25/05Veru to Present at the Jefferies Virtual Healthcare Conference
24/05Veru Announces Acceptance of Two Abstracts for Presentation at the American Society of ..
19/05VERU: Enrolls First Patient in Phase 3 Clinical Trial of Sabizabulin to Treat COVID-19; S..
19/05Veru Enrolls First Patient in Phase 3 Clinical Trial of Sabizabulin (VERU-111) in High ..
19/05Veru Enrolls First Patient in Phase 3 Clinical Trial of Sabizabulin (VERU-111) in High ..
18/05Certain Common Stock of Veru Inc. are subject to a Lock-Up Agreement Ending on 18-MAY-2..
18/05Certain Options of Veru Inc. are subject to a Lock-Up Agreement Ending on 18-MAY-2021.
14/05VERU INC.: Change in Directors or Principal Officers (form 8-K)
14/05Veru Inc. Announces Board Changes
14/05VERU: Reports Strong Second-Quarter Financial Results Based on Record High FC2 Prescripti..
12/05VERU: Management's Discussion and Analysis of Financial Condition and Results of Operatio..
12/05VERU: Earnings Flash (VERU) VERU Reports Q2 Loss $-0.04, vs. Street Est of $-0.03
12/05VERU: Earnings Flash (VERU) VERU Reports Q2 Revenue $13.3M, vs. Street Est of $14.3M
12/05Veru Reports Strong Second-Quarter Financial Results Based on Record High FC2 Prescript..
12/05Veru Inc. Reports Earnings Results for the Second Quarter Ended March 31, 2021
12/05EARNINGS REACTION HISTORY: VERU INC, 33.3% Follow-Through Indicator, 6.1% Sensitive
05/05Veru Announces the Presentation of Positive Phase 2 Clinical Data of Enobosarm in AR+ER..
05/05Veru Inc. Announces the Presentation of Positive Phase 2 Clinical Data of Enobosarm in ..
28/04Veru to Report Fiscal 2021 Second-Quarter Financial Results, Host Conference Call on Ma..
21/04Veru Announces Presentation of Phase 2 Study of Enobosarm -- a Selective Androgen Recep..
21/04Veru Inc. Announces Presentation of Phase 2 Study of Enobosarm -- a Selective Androgen ..
13/04VERU: Thinking about buying stock in IZEA Worldwide, WiMi Hologram Cloud, Veru, iHeartMed..
26/03VERU INC.: Submission of Matters to a Vote of Security Holders (form 8-K)
09/03VERU: to Present at the Oppenheimer 31st Annual Healthcare Conference
08/03Veru Explores Strategic Alternatives for Legacy Female Health Business
08/03VERU: to Explore 'Strategic Alternatives' for Legacy Female Health Business
08/03Veru Exploring Strategic Alternatives for its Legacy Female Health Business
02/03Veru to Participate in Fireside Chat at the H.C. Wainwright Global Life Sciences Confer..
02/03VERU: Receives FDA Agreement to Advance VERU-111 into Phase 3 Study in Hospitalized COVID..
01/03VERU: Gets FDA Approval for Veru-111 Phase 3 Study in Hospitalized COVID-19 Patients
01/03Veru Receives FDA Agreement to Advance VERU-111 into Phase 3 Study in Hospitalized COVI..
01/03Veru Inc. Receives FDA Agreement to Advance VERU-111 into Phase 3 Study in Hospitalized..
1  2  3  4  5Pross.